Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for Coagulation Dysfunction in Septic Shock
NCT02266589Phase 3Completed
- Sponsor
- General Hospital of Eastern Military Command
- Start
- Nov 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in septic shock comparing Hydrocortisone with Placebo (2 arms). Primary endpoint: Coagulopathy (ISTH DIC score) at 30 days. Started Nov 2011; status: completed.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02266589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266589.